CVE-2023-31222

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

28.49% probability of exploitation activity in the next 30 days.

EPSS percentile

Equal to or higher than the score of 97.9% of scored records. A rank, not a probability.

NVD base score

8.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2023-06-29 15:19Z3 YR AGO

Last updated

2024-11-26 19:27Z1 YR AGO

Reserved

2023-04-25

Assigning CNA

Medtronic

Record state

PUBLISHED

Severity

Critical (CVSS 9.8)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Weaknesses

• CWE-502Deserialization of Untrusted DataBase

Data version

5.1

Document digest

ba01b86f02413de8afad2da037fb0c15147fd330902666015cdd338a60363819

• global.medtronic.comhttps://global.medtronic.com/xg-en/product-security/security-bulletins/paceart-optima-system.html